Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022

SELL
$4.71 - $7.38 $800,700 - $1.25 Million
-170,000 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$5.2 - $8.42 $1.2 Million - $1.94 Million
-230,000 Reduced 57.5%
170,000 $1.24 Million
Q2 2021

Aug 12, 2021

BUY
$6.57 - $10.71 $2.63 Million - $4.28 Million
400,000 New
400,000 $3.44 Million

Others Institutions Holding FSTX

About F-star Therapeutics, Inc.


  • Ticker FSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,584,700
  • Description
  • F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...
More about FSTX
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.